ClinicalTrials.Veeva

Menu

Effect of Speech Enhancer on Listening Effort With EEG

Sonova logo

Sonova

Status

Invitation-only

Conditions

Listening Effort

Treatments

Other: Speech Enhancer

Study type

Interventional

Funder types

Industry
Other

Identifiers

Details and patient eligibility

About

In previous studies, Speech Enhancer has been shown to improve Listening Effort using a subjective method. To overcome the weakness of subjective testing, this study uses an objective measurement that has shown convincing results in previous studies addressing Listening Effort.

Full description

The Speech Enhancer (SE) provides better speech intelligibility for soft speech while maintaining the same sound quality for loud input level.

Better speech intelligibility may also result in less listening effort in some circumstances. So there was the hope that the SE provides better speech intelligibility and less listening effort for situation with soft speech.

The SE has already been intensely and successfully investigated in early studies.

The cognitive performance on a neurophiosiological level has already been successfully investigated in a previous studies.

Enrollment

27 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Experienced (minimum use duration 6 months)
  • Adult (minimum age: 18 years) hearing aid users,
  • Symmetrical hearing loss (difference between ears <= 10 dB for 1kHz-6kHz),
  • Sensorineural hearing loss,
  • Air Conduction - bone conduction gap <= 10 dB,
  • Written and spoken German,
  • Ability to understand instruction,
  • Ability to describe listening experiences,
  • Ability to attend to the appointments,
  • Healthy outer ear (without previous surgical proce-dures),
  • Hearing loss within the fitting ranges of the investiga-tional product,
  • Informed consent as documented by signature.

Exclusion criteria

  • Clinical contraindications deformity of the ear (closed ear canal or absence of pinna),
  • Known hypersensitivity or allergy,
  • Not willing to wear the hearing aid,
  • Fluctuating hearing that could influence the results,
  • Limited mobility and not in the position to attend all appointments,
  • Inability to produce a reliable hearing test result,
  • Massively limited dexterity,
  • Known psychological problems,
  • Known central hearing disorders.

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

27 participants in 1 patient group

Hearing impaired group
Experimental group
Description:
The hearing impaired group will compare the reference condition (SpeechEnhancer on) with the intervention condition (SpeechEnhancer off).
Treatment:
Other: Speech Enhancer

Trial contacts and locations

1

Loading...

Central trial contact

Julia Habicht; Martina Schuepbach-Wolf

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems